Parathyroid Hormone in the Treatment of Osteoporosis

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.11, 2001-01, pp. : 721-728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Full-Length Parathyroid Hormone (1-84): Profile Report

By Moen Marit D. Scott Lesley J.

BioDrugs, Vol. 21, Iss. 3, 2007-01 ,pp. : 205-208

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Calcitonin in the Prevention and Treatment of Osteoporosis

By Reginster Y. Reginster J-Y.

BioDrugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 295-300

Adis International

Access to resources Recommend Favorite

Anti-Gonadotropin Releasing Hormone Vaccines and Their Potential Use in the Treatment of Hormone-Responsive Cancers

By Ferro V.A. Stimson W.H.

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Recombinant Human Growth Hormone: Rationale for Use in the Treatment of HIV-Associated Lipodystrophy

By Benedini Stefano

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Clinical Experience with Growth Hormone Treatment in Patients with -Thalassaemia Major

By Sanctis V.D. Urso L.

BioDrugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 79-85

Adis International

Access to resources Recommend Favorite